SC
DMTK

Saltoro Capital’s DermTech, Inc. Common Stock DMTK Stock Holding History

Saltoro Capital’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,400
Closed -$935K – 133
2021
Q1 		$935K Buy
+18,400
New +$962K 0.23% 51

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Saltoro Capital's DMTK Position: Q2 2021 in Review

Saltoro Capital sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 18,400 shares — an estimated $935K sold.

Saltoro Capital first reported a position in DMTK in Q1 2021 and held it in 1 quarter. The position peaked at $935K in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Saltoro Capital reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Saltoro Capital sold 18,400 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $935K.
  • Saltoro Capital first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Saltoro Capital's DermTech, Inc. Common Stock position peaked at $935K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Saltoro Capital's 13F filing for Q2 2021, filed 12 Aug 2021.